Â鶹Éç

We are rethinking how dementia is diagnosed by upgrading the convetional MRI technology to conduct metabolic imaging, removing the need for radioactive PET scans. Using deuterium-labeled glucose detected indirectly through standard brain MRI signals, we aim to produce detailed images that allow for early and precise dementia diagnosis. This cutting-edge method reduces costs, eliminates radiation exposure, and streamlines clinical processes. With this grant, we plan to develop advanced AI enhanced imaging techniques, offering a safer, non-invasive solution for dementia patients to enhance their care and treatment outcomes.